Overall rank by patents
#4,628
Across all tracked assignees
USPTO PatentsView assignee record - 76 granted patents across 40 technology areas, active 2015–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G02F (OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICA).
The verdict
Kinestral holds 76 US patents across 40 technology areas, rank #4,628 of 50,000 tracked assignees.
Kinestral Technologies, Inc. has been granted 76 US utility patents between 2015 and 2021, placing Kinestral Technologies, Inc. at rank #4,628 across all assignees tracked by PlainPatent. This portfolio spans 40 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.4 claims per patent with primary concentration in G02F (OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICA). As a US Corporation, Kinestral Technologies, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Kinestral sits between Hydro-quebec (76 patents, rank #4,624) and M&K Holdings Inc. (76 patents, rank #4,632) - the closest US assignees by grant volume. The composite Innovation Score of 49.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 37 grants, compared with 39 in the 2015–2019 window, a -5% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Kinestral Technologies, Inc.'s 19.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 40 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Kinestral Technologies, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Hydro-Quebec
76 patents
INSTANT BRANDS HOLDINGS INC.
76 patents
INSTITUT NATIONAL D'OPTIQUE
76 patents
INSTITUT POLYTECHNIQUE DE BORDEAUX
76 patents
KPR U.S., LLC
76 patents
KYUSHU INSTITUTE OF TECHNOLOGY
76 patents
LIVSMED INC.
76 patents
M&K Holdings Inc.
76 patents
KINESTRAL TECHNOLOGIES, INC.
76 patents
What this shows Kinestral holds 76 patents at rank #4,628, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,628 in granted patent volume.
Other assignees with the most granted patents in Kinestral's primary technology class.
Kinestral's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 15% higher than 85% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 5.3% |
| 2016 | 8 | 10.5% |
| 2017 | 9 | 11.8% |
| 2018 | 6 | 7.9% |
| 2019 | 12 | 15.8% |
| 2020 | 25 | 32.9% |
| 2021 | 12 | 15.8% |
Top 15 of 40 technology areas
Overall rank by patents
#4,628
Across all tracked assignees
49.0 out of 100
How to use this portfolio
Kinestral's 76 grants land it in the top 15% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.